Gracell Biotechnologies (Gracell Biotechnologies) Price-to-Tangible-Book : 4.43 (As of May. 10, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Gracell Biotechnologies Price-to-Tangible-Book?

As of today (2024-05-10), Gracell Biotechnologies's share price is $10.25. Gracell Biotechnologies's Tangible Book per Share of Sep. 2023 for the quarter that ended in Sep. 2023 was $2.32. Hence, Gracell Biotechnologies's Price to Tangible Book Ratio of today is 4.43.

The historical rank and industry rank for Gracell Biotechnologies's Price-to-Tangible-Book or its related term are showing as below:

GRCL' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.6 Med: 1.42 Max: 4.43
Current: 4.42

During the past 5 years, Gracell Biotechnologies's highest Price to Tangible Book Ratio was 4.43. The lowest was 0.60. And the median was 1.42.

GRCL's Price-to-Tangible-Book is not ranked
in the Biotechnology industry.
Industry Median: 2.75 vs GRCL: 4.42

A closely related ratio is called PB Ratio. As of today, Gracell Biotechnologies's share price is $10.25. Gracell Biotechnologies's Book Value per Sharefor the quarter that ended in Sep. 2023 was $2.32. Hence, Gracell Biotechnologies's P/B Ratio of today is 4.43.

Gracell Biotechnologies Price-to-Tangible-Book Historical Data

The historical data trend for Gracell Biotechnologies's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gracell Biotechnologies Price-to-Tangible-Book Chart

Gracell Biotechnologies Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Price-to-Tangible-Book

1.42

0.79

Gracell Biotechnologies Quarterly Data
	Dec18	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Price-to-Tangible-Book	Get a 7-Day Free Trial													1.00	0.79	0.72	1.64	1.24

Competitive Comparison of Gracell Biotechnologies's Price-to-Tangible-Book

For the Biotechnology subindustry, Gracell Biotechnologies's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gracell Biotechnologies's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Gracell Biotechnologies's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Gracell Biotechnologies's Price-to-Tangible-Book falls into.

Gracell Biotechnologies Price-to-Tangible-Book Calculation

Gracell Biotechnologies's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Sep. 2023 )
	=	10.25	/	2.316
	=	4.43

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Gracell Biotechnologies Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Gracell Biotechnologies's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Gracell Biotechnologies (Gracell Biotechnologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gracell Biotechnologies Inc (NAS:GRCL) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

N/A

Address

218 Sangtian Street, Building 12, Block B, Phase II, Biobay Industrial Park, Suzhou Industrial Park, Suzhou, CHN, 215123

Website

https://www.gracellbio.com

Gracell Biotechnologies Inc is a clinical-stage biopharmaceutical company focused on developing and discovering cell and gene therapies to address and fulfill unmet medical needs in the treatment of cancer. The company aims to disrupt conventional approaches to CAR-T cell therapies with its proprietary technology platforms-FasTCAR and TruUCAR.